- Home
- IPHA vs TTEC Comparison
IPHA vs TTEC Comparison
Compare IPHA & TTEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- TTEC
- Stock Information
- Founded
- IPHA 1999
- TTEC 1982
- Country
- IPHA France
- TTEC United States
- Employees
- IPHA N/A
- TTEC N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- TTEC Retail: Computer Software & Peripheral Equipment
- Sector
- IPHA Health Care
- TTEC Technology
- Exchange
- IPHA Nasdaq
- TTEC Nasdaq
- Market Cap
- IPHA 160.1M
- TTEC 177.9M
- IPO Year
- IPHA 2019
- TTEC 1996
- Fundamental
- Price
- IPHA $2.16
- TTEC $3.79
- Analyst Decision
- IPHA Strong Buy
- TTEC Hold
- Analyst Count
- IPHA 1
- TTEC 3
- Target Price
- IPHA $11.00
- TTEC $3.50
- AVG Volume (30 Days)
- IPHA 6.4K
- TTEC 555.7K
- Earning Date
- IPHA 09-17-2025
- TTEC 08-07-2025
- Dividend Yield
- IPHA N/A
- TTEC N/A
- EPS Growth
- IPHA N/A
- TTEC N/A
- EPS
- IPHA N/A
- TTEC N/A
- Revenue
- IPHA $20,831,349.00
- TTEC $2,144,663,000.00
- Revenue This Year
- IPHA $350.96
- TTEC N/A
- Revenue Next Year
- IPHA $32.92
- TTEC $0.47
- P/E Ratio
- IPHA N/A
- TTEC N/A
- Revenue Growth
- IPHA N/A
- TTEC N/A
- 52 Week Low
- IPHA $1.29
- TTEC $2.67
- 52 Week High
- IPHA $3.51
- TTEC $6.28
- Technical
- Relative Strength Index (RSI)
- IPHA 52.85
- TTEC 46.22
- Support Level
- IPHA $2.04
- TTEC $3.52
- Resistance Level
- IPHA $2.20
- TTEC $3.88
- Average True Range (ATR)
- IPHA 0.10
- TTEC 0.20
- MACD
- IPHA -0.02
- TTEC 0.07
- Stochastic Oscillator
- IPHA 33.83
- TTEC 73.68
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About TTEC TTEC Holdings Inc.
TTEC Holdings Inc provides customer engagement management tools and services. The company operates through four operating segments that are organized into two groups, TTEC Digital and TTEC Engage. TTEC Digital is engaged in building and implementing cloud-based and on-premises customer experience tools that enable clients to develop customer engagement strategies. TTEC Engage focuses on delivering sales and marketing solutions to help clients boost their revenue as well as on managing customer's front-to-back office processes to optimize the customer experience. TTEC Engage contributes the vast majority of the company's revenue, and its sales are derived from the United States and Canada, followed by Philippines, Asia-Pacific and India.